e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pretreatment Evaluation on Non-Small-cell Lung Cancer
ATS Board of Directors, March 1997 and by the ERS Executive Committee , April 1997
Source:
Guideline 1997
Number:
1998
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
ATS Board of Directors, March 1997 and by the ERS Executive Committee , April 1997. Pretreatment Evaluation on Non-Small-cell Lung Cancer. Guideline 1997
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Lung Micobiome in Lung Cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
The Role Of TGF-ß in Lung Cancer Development in COPD Patients
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Lung Microbiota and Streptococcal enrichment in Central Lung Cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
The Burden of Asymptomatic Lung Cancer
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019
Lung Cancer vs. „Young Cancer“ – Is There a Difference?
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
Intratumoral Hyperthermic Chemotherapy Injection in Peripheral Non-Small Cell Lung Cancer; a Pilot Study.
Source: Virtual Congress 2020 – Novelties in interventional pulmonology: expanding horizons
Year: 2020
Resected Non-Small Cell Lung Cancer : A 5-year Experience
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019
Clinical Features and Treatment Outcome of Carcinomatous Pericarditis due to Lung Cancer.
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
Determinants of Respiratory Muscle Strength in Lung Cancer
Source: International Congress 2019 – New views on testing and training of respiratory muscles
Year: 2019
Short Term Multidisciplinary Pulmonary Rehabilitation Is Effective In Early Stage Non Small Cell Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
Consequences of Lung Cancer: Mortality and Comorbidity in Danish Patients with Lung Cancer 1998-2010
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019
Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST)
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018
Pathology of Vaping-Associated Lung Injury
Source: Virtual Congress 2020 – E-cigarette or Vaping, product use Associated Lung Injury (EVALI)
Year: 2020
NRG1 Fusion-Positive Lung Cancers: Clinicopathologic Profile and Treatment Outcomes from a Global Multicenter Registry
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Cancer
Source: Eur Respir Monogr 2016; 71: 151-159
Year: 2016
Lung Cancer and bronchial infection
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Impact of Emphysema Heterogeneity on Lung Function after Bronchoscopic Lung Volume Reduction
Source: International Congress 2019 – Interventional pulmonology: re-sculpting the airway
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept